Abstract
The development of a 99mTc-radiotracer for imaging of β-amyloid (Aβ) plaques with single photon emission computed tomography (SPECT) is strongly anticipated to provide a low cost and broadly accessible diagnostic tool for Alzheimer's disease (AD). Within this framework, 2-(4′-aminophenyl)benzothiazole, known to display affinity and specificity for Aβ plaques, has been joined to the tricarbonyl fac-[M(CO)3]+ (M = Re(I), 99mTc(I)) core through the cyclopentadienyl moiety to yield stable, neutral, and lipophilic complexes (Re-1 and 99mTc-1, respectively). The Re-1 complex was completely characterized with spectroscopic methods and was shown to selectively stain Aβ plaques on sections of human AD brain tissue. The 99mTc-1 complex displayed satisfactory initial brain uptake (0.53% ID/g at 2 min) and in vivo stability in healthy mice, while in transgenic 5xFAD mice, models for AD, a notable retention in the brain was noted (1.94% ID/g at 90 min). The results are encouraging and contribute to the effort of developing a SPECT amyloid imaging agent.
Original language | English |
---|---|
Pages (from-to) | 1089-1092 |
Number of pages | 4 |
Journal | Acs Medicinal Chemistry Letters |
Volume | 8 |
Issue number | 10 |
DOIs | |
Publication status | Published - 12 Oct 2017 |
Keywords
- Tc
- 2-(4′-Aminophenyl)benzothiazole
- cyclopentadienyl
- Re
- SPECT imaging
- β-amyloid plaques